NCT03386448View on ClinicalTrials.gov

The Safety and Efficacy of Naltrexone and Scopolamine Utilized in the Treatment of Major Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

November 20, 2018

Study Completion Date

November 20, 2018

Conditions
Depression
Interventions
DRUG

Scopolamine and naltrexone

participants will receive scopolamine and naltrexone in buccal drops

DRUG

placebo arm

participants will receive placebo medications

Trial Locations (1)

28211

The Taub Group, Charlotte

All Listed Sponsors
lead

The Taub Group

INDUSTRY

NCT03386448 - The Safety and Efficacy of Naltrexone and Scopolamine Utilized in the Treatment of Major Depression | Biotech Hunter | Biotech Hunter